Literature DB >> 1560754

Conditions for transformation of Pasteurella multocida by electroporation.

L Jablonski1, N Sriranganathan, S M Boyle, G R Carter.   

Abstract

Conditions for electroporation of plasmid DNA into Pasteurella multocida were determined for use in developing a cloning system to study virulence factors of P. multocida. The highest efficiency of transformation (1.25 x 10(7) cfu/micrograms DNA) was obtained when 7.6 x 10(10) cells of P. multocida strain R473 were electroporated at 12.5 kV/cm (10 ms, 5 ng of pVM109). Transformation efficiencies of cells prepared at mid-log-phase were approximately 0.5 log10 lower than early, late, or stationary phases. Neither pBR322 nor pUC-19 were able to transform strain R473 under these conditions, even when DNA concentrations were increased to 1 microgram. When pBR322 was ligated with a Pasteurella plasmid, pLAR-1, the hybrid was able to transform strain R473 at an efficiency between 4.5 x 10(2) and 8 x 10(4) cfu/micrograms DNA. Six strains of P. multocida including serotypes A, B, D, and E were transformed successfully.

Entities:  

Mesh:

Year:  1992        PMID: 1560754     DOI: 10.1016/0882-4010(92)90066-w

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  10 in total

1.  Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?

Authors:  Andrew N Rycroft; Ken C Smith; Rob Noad; Dirk Werling
Journal:  Vet Rec       Date:  2020-06-26       Impact factor: 2.695

2.  The influence of the growth phase of enteric bacteria on electrotransformation with plasmid DNA.

Authors:  M Szostková; D Horáková; M Nĕmec
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

3.  The Pasteurella multocida nrfE gene is upregulated during infection and is essential for nitrite reduction but not for virulence.

Authors:  David J Boucher; Ben Adler; John D Boyce
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 4.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  The capsule is a virulence determinant in the pathogenesis of Pasteurella multocida M1404 (B:2).

Authors:  J D Boyce; B Adler
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  The pnhA gene of Pasteurella multocida encodes a dinucleoside oligophosphate pyrophosphatase member of the Nudix hydrolase superfamily.

Authors:  Tonia Urick; Chien I-Chang; Ellen Arena; Wenlian Xu; Maurice J Bessman; Carmel G Ruffolo
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

7.  Evolutionary stability of DNA uptake signal sequences in the Pasteurellaceae.

Authors:  M Bakkali; T-Y Chen; H C Lee; R J Redfield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

8.  Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia.

Authors:  Mohammad Tabatabaei; Zhiqi Liu; Anna Finucane; Roger Parton; John Coote
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  Is the production of a Covid-19 vaccine using transformed Pasteurella plausible?

Authors:  Andrew N Rycroft; Ken C Smith; Rob Noad; Dirk Werling
Journal:  Vet Rec       Date:  2020-07       Impact factor: 2.560

10.  Capsular Polysaccharide Interferes with Biofilm Formation by Pasteurella multocida Serogroup A.

Authors:  Briana Petruzzi; Robert E Briggs; Fred M Tatum; W Edward Swords; Cristina De Castro; Antonio Molinaro; Thomas J Inzana
Journal:  MBio       Date:  2017-11-21       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.